Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization

NCT07241884 is registered in ClinicalTrials.gov with CrannMed as lead sponsor.

NCT NCT07241884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07241884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization
Lead sponsor
CrannMed
Phase
Not applicable
Overall status
Recruiting
Start date
October 20, 2025
Completion date
March 31, 2027
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heel pain, musculoskeletal diseases, plantar fascitis